Signal
New insights into RBM20 variants in cardiomyopathy and plasma proteins linked to rheumatoid arthritis
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-06-11 23:04 UTCUpdated 2026-06-12 03:44 UTC
rss
clinical_trialsgenomicsrddrug_developmentsafety_signals
Trend in the last 24h
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
Recent research advances molecular understanding of dilated cardiomyopathy (DCM) and rheumatoid arthritis (RA) through large-scale protein and variant analyses.
Entities
RBM20 variant functional mappingPlasma protein prioritisation in rheumatoid arthritisFenzl, K.Mueller, L. H.Kornienko, J.Majchrowska, M.Eikmeier, N.Wehnert, B.
Score total
0.96
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
0%
Why now
- New high-throughput molecular phenotyping enables large-scale functional mapping of disease variants.
- Large-scale proteomic and genetic datasets facilitate causal protein prioritization in complex diseases.
- Findings support precision medicine approaches in cardiomyopathy and autoimmune disease management.
Why it matters
- Improves clinical interpretation of RBM20 variants in dilated cardiomyopathy for better patient stratification.
- Identifies causal plasma proteins in rheumatoid arthritis, revealing novel drug targets.
- Highlights shared molecular pathways between autoimmune and cardiometabolic diseases, aiding therapeutic development.
LLM analysis
Topic mix: lowPromo risk: lowSource quality: medium
Recurring claims
- RBM20 variant functional mapping predicts variant impact and stratifies dilated cardiomyopathy into mechanistic classes.
- Mendelian randomisation identifies 37 plasma proteins causally linked to rheumatoid arthritis risk, revealing druggable targets.
How sources frame it
- Fenzl Et Al.: neutral
- Alduhayhi Et Al.: neutral
This narrative highlights complementary advances in variant functional mapping and proteomic causal inference that enhance understanding and therapeutic targeting in cardiomyopathy and rheumatoid arthritis.
All evidence
All evidence
Multimodal phenotyping defines variant-to-function maps for RBM20 in dilated cardiomyopathy
bioRxiv (all subjects) · biorxiv.org · 2026-06-12 03:44 UTC
Plasma protein prioritisation in rheumatoid arthritis reveals druggable targets and shared biology with cardiovascular diseases
medRxiv (all subjects) · medrxiv.org · 2026-06-11 23:04 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- bioRxiv (all subjects) (1)
- medRxiv (all subjects) (1)
Top origin domains (this list)
- biorxiv.org (1)
- medrxiv.org (1)